WuXi AppTec (TIDES)

Chinese pharmaceutical services company. Operates 20+ solid-phase peptide synthesis lines. Passed 2025 FDA inspection with zero observations. Provides peptide API and custom synthesis services with established global export logistics.

WuXi AppTec (TIDES) is listed as a CDMO in the peptide supply chain, serving Asia markets from China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 3 independent sources, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.